医薬品受託包装市場レポート：産業、タイプ、包装、地域別、2024年～2032年

世界の医薬品受託包装市場規模は2023年に217億米ドルに達しました。今後、IMARC Groupは、2024年から2032年の間に6.8%の成長率（CAGR）を示し、市場は2032年までに399億米ドルに達すると予測しています。アウトソーシング動向の高まり、医薬品・医療機器需要の増加、厳格な規制対応、製品の多様化と費用対効果、大幅な技術進歩、環境配慮の高まりなどが市場を後押しする主な要因です。

医薬品受託包装とは、製薬会社が専門の受託包装会社に包装サービスを委託することを指します。これらの企業は、医薬品、医療機器、関連ヘルスケアアイテムを含む医薬品の包装を処理するために必要なインフラと専門知識を備えています。医薬品受託包装のプロセスには、デザイン、ラベリング、最終製品パッケージの組み立てなど、さまざまな段階が含まれます。受託包装会社は、規制ガイドラインや、適正製造基準（GMP）や品質保証（QA）プロトコルなどの業界標準への準拠を保証します。受託包装サービスを選択することで、製薬会社はいくつかのメリットを享受することができます。専門家にパッケージングを任せながら、研究開発などのコアコンピタンスに集中することができます。その結果、業務効率が向上し、製品の市場投入までの時間が短縮されます。さらに、受託包装会社は、規模の経済を活用し、包装工程を最適化することで、費用対効果の高いソリューションを提供することができます。

製薬会社は、包装を含む非中核業務を包装受託会社にアウトソーシングするケースが増えています。これにより、製薬会社は研究開発などのコアコンピタンスに集中することができ、同時に受託包装のスペシャリストの専門知識と効率性の恩恵を受けることができます。さらに、製薬業界は世界中の保健当局から厳しい規制や品質基準を課されています。受託包装会社はこれらの規制に精通しており、医薬品が適正製造基準（GMP）やその他の関連ガイドラインに準拠して包装・表示されることを保証します。この他にも、新薬開拓、個別化医薬品、革新的な医療機器など、医薬品市場は絶えず拡大しています。受託包装会社は、これらの製品の多様な包装要件に対応するため、カスタマイズされた柔軟なソリューションを提供しています。これに加えて、受託包装は包装インフラや設備への多額の投資を不要にすることで、製薬会社にコスト面でのメリットを提供します。その代わりに、製薬会社は確立された受託包装業者の能力を活用することができ、コスト削減につながります。これに伴い、世界の製薬業界は、特に新興市場において著しい成長を遂げています。製薬会社は新たな地域への進出を拡大する中、多様な市場で効率的かつコンプライアンスに準拠した包装を行うため、信頼できる包装受託パートナーを求めています。さらに、受託パッケージング企業は、そのプロセスに先進技術と自動化を継続的に採用しています。これらの技術革新は包装効率を向上させ、エラーを減らし、全体的な生産性を高めるため、製薬会社にとって魅力的なパートナーとなっています。さらに、持続可能性と環境への影響に対する意識の高まりにより、環境に優しくリサイクル可能な包装ソリューションに対する需要が高まっています。受託包装企業は、市場の需要に応えるため、こうした環境に配慮した取り組みに沿った製品を提供しています。

医薬品包装受託市場の動向と促進要因：

アウトソーシング動向の高まり

製薬会社は、包装のニーズを処理するために包装請負会社を利用するようになってきています。このシフトは主に、医薬品開発やマーケティングなどのコアコンピタンスに集中する一方で、パッケージングという専門的な作業を経験豊富な専門家に任せたいという願望によるものです。包装をアウトソーシングすることで、製薬会社は業務を合理化し、運営コストを削減し、全体的な効率を向上させることができます。受託包装会社は、包装材料、デザイン、法規制遵守に関する専門知識を提供するため、製薬会社は高品質の製品をタイムリーに市場に供給することができます。さらに、アウトソーシングは製品需要の変動に柔軟に対応できるため、製薬会社は市場力学の変化に迅速に対応することができます。

厳しい規制への対応

製薬業界は、患者の安全性と製品の有効性を確保するため、世界中の様々な保健当局から厳しい規制を受けています。製薬企業にとって、適正製造基準（GMP）やその他の規制ガイドラインの遵守は最も重要です。受託包装会社は、適用される品質基準や業界のベストプラクティスに関する深い知識を有しているため、このような厳しい規制の遵守を専門としています。彼らの専門知識により、医薬品は正確にラベル付けされ、包装され、サプライチェーン全体を通してトレーサブルであることが保証され、コンプライアンス違反や潜在的な法的問題のリスクを低減します。受託包装プロバイダーと提携することで、製薬会社は安全で信頼性の高い製品を製造するという評判を維持しながら、規制違反に関連するリスクを軽減することができます。

医薬品と医療機器の需要増加

世界の医薬品市場は継続的に拡大しており、医薬品や医療機器の需要は多様な地域で増加しています。製薬会社は新規市場への参入を目指す中で、独自の包装要件や地域規制に遭遇します。コントラクト・パッケージング企業は、各地域に特化した専門知識と能力を提供し、製薬会社が異なる市場の複雑さをシームレスに乗り切ることを可能にします。これらの企業は、現地の規制や文化的嗜好に適合するよう、パッケージデザイン、ラベリング、言語翻訳を適応させることができます。受託パッケージングプロバイダーと提携することで、製薬会社は効率的に新市場に参入し、成長機会を活用し、より幅広い顧客層にアプローチすることができます。この市場拡大戦略により、製薬会社はロジスティクスの課題を最小限に抑え、一貫したコンプライアンスに準拠したパッケージング・アプローチを確保しながら、市場でのプレゼンスを拡大することができます。

目次

第1章 序文

第2章 調査範囲と調査手法

• 調査目的
• 利害関係者
• データソース
  • 一次情報
  • 二次情報
• 市場推定
  • ボトムアップアプローチ
  • トップダウンアプローチ
• 調査手法

第3章 エグゼクティブサマリー

第4章 イントロダクション

• 概要
• 主要業界動向

第5章 世界の医薬品受託包装業界

• 市場概要
• 市場実績
• COVID-19の影響
• 価格分析
  • 主要価格指標
  • 価格構造
  • 価格動向
• 市場内訳：産業別
• 市場内訳：タイプ別
• 市場内訳：包装別
• 市場内訳：地域別
• 市場予測
• SWOT分析
  • 概要
  • 強み
  • 弱み
  • 機会
  • 脅威
• バリューチェーン分析
  • 原材料調達
  • 製造
  • マーケティング
  • 流通
  • 輸出
  • 最終用途
• ポーターのファイブフォース分析
  • 概要
  • 買い手の交渉力
  • 供給企業の交渉力
  • 競合の程度
  • 新規参入業者の脅威
  • 代替品の脅威
• ジェネリック医薬品業界における規制
• 市場促進要因と成功要因

第6章 市場内訳：産業別

• 低分子医薬品
  • 市場動向
  • 市場予測
• バイオ医薬品
  • 市場動向
  • 市場予測
• ワクチン
  • 市場動向
  • 市場予測

第7章 市場内訳：タイプ別

• 滅菌
  • 市場動向
  • 市場予測
• 非滅菌
  • 市場動向
  • 市場予測

第8章 市場内訳：包装別

• プラスチックボトル
  • 市場動向
  • 市場予測
• キャップ・クロージャー
  • 市場動向
  • 市場予測
• ブリスターパック
  • 市場動向
  • 市場予測
• プレフィルドシリンジ
  • 市場動向
  • 市場予測
• 非経口バイアルとアンプル
  • 市場動向
  • 市場予測
• その他
  • 市場動向
  • 市場予測

第9章 市場内訳：地域別

• 米国
  • 市場動向
  • 市場予測
• 欧州
  • 市場動向
  • 市場予測
• 中国市場
  • 市場動向
  • 市場予測
• インド
  • 市場動向
  • 市場予測
• その他
  • 市場動向
  • 市場予測

第10章 競合情勢

• 市場構造
• 主要企業

第11章 医薬品受託包装プロセス

• 製品概要
• 詳細なプロセスフロー
• 関与する様々な種類の単位操作
• マスバランスと原材料要件

第12章 プロジェクトの詳細、必要条件、費用

• 土地要件と費用
• 建設要件と費用
• 工場レイアウト
• 工場機械
• 原材料の要件と支出
• 輸送要件と経費
• ユーティリティの要件と支出
• 必要人員と支出
• その他の設備投資

第13章 融資と資金援助

第14章 プロジェクトの経済性

• プロジェクトの資本コスト
• 技術経済的パラメーター
• サプライチェーンの各段階における製品価格とマージン
• 課税と減価償却
• 収入予測
• 支出予測
• 財務分析
• 利益分析

第15章 主要プレーヤーのプロファイル

List of Figures

• Figure 1: Global: Pharmaceutical Contract Packaging Market: Major Drivers and Challenges
• Figure 2: Global: Pharmaceutical Contract Packaging Market: Sales Value Trends (in Billion US$), 2018-2023
• Figure 3: Global: Pharmaceutical Contract Packaging Market Forecast: Sales Value Trends (in Billion US$), 2024-2032
• Figure 4: Global: Pharmaceutical Contract Packaging Market: Breakup by Industry (in %), 2023
• Figure 5: Global: Pharmaceutical Contract Packaging Market: Breakup by Type (in %), 2023
• Figure 6: Global: Pharmaceutical Contract Packaging Market: Breakup by Packaging (in %), 2023
• Figure 7: Global: Pharmaceutical Contract Packaging Market: Breakup by Region (in %), 2023
• Figure 8: Global: Pharmaceutical Contract Packaging Industry: SWOT Analysis
• Figure 9: Global: Pharmaceutical Contract Packaging Industry: Value Chain Analysis
• Figure 10: Global: Pharmaceutical Contract Packaging Industry: Porter's Five Forces Analysis
• Figure 11: United States: Pharmaceutical Contract Packaging Market (in Million US$), 2018 & 2023
• Figure 12: United States: Pharmaceutical Contract Packaging Market Forecast (in Million US$), 2024-2032
• Figure 13: Europe: Pharmaceutical Contract Packaging Market (in Million US$), 2018 & 2023
• Figure 14: Europe: Pharmaceutical Contract Packaging Market Forecast (in Million US$), 2024-2032
• Figure 15: China: Pharmaceutical Contract Packaging Market (in Million US$), 2018 & 2023
• Figure 16: China: Pharmaceutical Contract Packaging Market Forecast (in Million US$), 2024-2032
• Figure 17: India: Pharmaceutical Contract Packaging Market (in Million US$), 2018 & 2023
• Figure 18: India: Pharmaceutical Contract Packaging Market Forecast (in Million US$), 2024-2032
• Figure 19: Others: Pharmaceutical Contract Packaging Market (in Million US$), 2018 & 2023
• Figure 20: Others: Pharmaceutical Contract Packaging Market Forecast (in Million US$), 2024-2032
• Figure 21: Global: Pharmaceutical Contract Packaging (Small Molecule) Market: Sales Value (in Million US$), 2018 & 2023
• Figure 22: Global: Pharmaceutical Contract Packaging (Small Molecule) Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 23: Global: Pharmaceutical Contract Packaging (Biopharmaceutical) Market: Sales Value (in Million US$), 2018 & 2023
• Figure 24: Global: Pharmaceutical Contract Packaging (Biopharmaceutical) Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 25: Global: Pharmaceutical Contract Packaging (Vaccine) Market: Sales Value (in Million US$), 2018 & 2023
• Figure 26: Global: Pharmaceutical Contract Packaging (Vaccine) Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 27: Global: Pharmaceutical Contract Packaging (Sterile) Market: Sales Value (in Million US$), 2018 & 2023
• Figure 28: Global: Pharmaceutical Contract Packaging (Sterile) Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 29: Global: Pharmaceutical Contract Packaging (Non-Sterile) Market: Sales Value (in Million US$), 2018 & 2023
• Figure 30: Global: Pharmaceutical Contract Packaging (Non-Sterile) Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 31: Global: Pharmaceutical Contract Packaging (Plastic Bottles) Market: Sales Value (in Million US$), 2018 & 2023
• Figure 32: Global: Pharmaceutical Contract Packaging (Plastic Bottles) Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 33: Global: Pharmaceutical Contract Packaging (Caps and Closures) Market: Sales Value (in Million US$), 2018 & 2023
• Figure 34: Global: Pharmaceutical Contract Packaging (Caps and Closures) Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 35: Global: Pharmaceutical Contract Packaging (Blister Packs) Market: Sales Value (in Million US$), 2018 & 2023
• Figure 36: Global: Pharmaceutical Contract Packaging (Blister Packs) Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 37: Global: Pharmaceutical Contract Packaging (Prefilled Syringes) Market: Sales Value (in Million US$), 2018 & 2023
• Figure 38: Global: Pharmaceutical Contract Packaging (Prefilled Syringes) Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 39: Global: Pharmaceutical Contract Packaging (Parenteral Vials and Ampoules) Market: Sales Value (in Million US$), 2018 & 2023
• Figure 40: Global: Pharmaceutical Contract Packaging (Parenteral Vials and Ampoules) Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 41: Global: Pharmaceutical Contract Packaging (Others) Market: Sales Value (in Million US$), 2018 & 2023
• Figure 42: Global: Pharmaceutical Contract Packaging (Others) Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 43: Pharmaceutical Contract Packaging: Detailed Process Flow
• Figure 44: Pharmaceutical Contract Packaging: Conversion Rate of Feedstocks
• Figure 45: Pharmaceutical Contract Packaging Plant: Proposed Plant Layout
• Figure 46: Pharmaceutical Contract Packaging Plant: Breakup of Capital Costs (in %)
• Figure 47: Pharmaceutical Contract Packaging Industry: Profit Margins at Various Levels of the Supply Chain
• Figure 48: Pharmaceutical Contract Packaging Plant: Production Cost Breakup (in %)

List of Tables

• Table 1: Global: Pharmaceutical Contract Packaging Market: Key Industry Highlights, 2023 and 2032
• Table 2: Global: Pharmaceutical Contract Packaging Market Forecast: Breakup by Industry (in Million US$), 2024-2032
• Table 3: Global: Pharmaceutical Contract Packaging Market Forecast: Breakup by Type (in Million US$), 2024-2032
• Table 4: Global: Pharmaceutical Contract Packaging Market Forecast: Breakup by Packaging (in Million US$), 2024-2032
• Table 5: Global: Pharmaceutical Contract Packaging Market Forecast: Breakup by Region (in Million US$), 2024-2032
• Table 6: Global: Pharmaceutical Contract Packaging Market: Competitive Structure
• Table 7: Global: Pharmaceutical Contract Packaging Market: Key Players
• Table 8: Pharmaceutical Contract Packaging Plant: Costs Related to Land and Site Development (in US$)
• Table 9: Pharmaceutical Contract Packaging Plant: Costs Related to Civil Works (in US$)
• Table 10: Pharmaceutical Contract Packaging Plant: Costs Related to Machinery Unit (in US$)
• Table 11: Pharmaceutical Contract Packaging Plant: Raw Material Requirements (in Tons/Day) and Expenditures (in US$/Ton)
• Table 12: Pharmaceutical Contract Packaging Plant: Costs Related to Salaries and Wages (in US$)
• Table 13: Pharmaceutical Contract Packaging Plant: Costs Related to Other Capital Investments (in US$)
• Table 14: Details of Financial Assistance Offered by Financial Institutions
• Table 15: Pharmaceutical Contract Packaging Plant: Capital Costs (in US$)
• Table 16: Pharmaceutical Contract Packaging Plant: Techno-Economic Parameters
• Table 17: Pharmaceutical Contract Packaging Plant: Taxation and Depreciation (in US$)
• Table 18: Pharmaceutical Contract Packaging Plant: Income Projections (in US$)
• Table 19: Pharmaceutical Contract Packaging Plant: Expenditure Projections (in US$)
• Table 20: Pharmaceutical Contract Packaging Plant: Cash Flow Analysis Without Considering the Income Tax Liability (in US$)
• Table 21: Pharmaceutical Contract Packaging Plant: Cash Flow Analysis on Considering the Income Tax Liability (in US$)
• Table 22: Pharmaceutical Contract Packaging Plant: Profit and Loss Account (in US$)

The global pharmaceutical contract packaging market size reached US$ 21.7 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 39.9 Billion by 2032, exhibiting a growth rate (CAGR) of 6.8% during 2024-2032. The increasing outsourcing trends, rising demand for medications and medical devices, stringent regulatory compliance, product diversification and cost-effectiveness, significant technological advancements, and increasing environmental considerations are some of the major factors propelling the market.

Pharmaceutical contract packaging refers to the outsourcing of packaging services by pharmaceutical companies to specialized contract packaging firms. These firms are equipped with the necessary infrastructure and expertise to handle the packaging of pharmaceutical products, including medications, medical devices, and related healthcare items. The process of pharmaceutical contract packaging involves various stages, including design, labeling, and assembly of the final product packaging. The contract packaging companies ensure compliance with regulatory guidelines and industry standards, such as Good Manufacturing Practices (GMP) and Quality Assurance (QA) protocols. By opting for contract packaging services, pharmaceutical companies can benefit from several advantages. It allows them to focus on their core competencies, such as research and development, while entrusting packaging responsibilities to experts. This leads to increased operational efficiency and reduced time-to-market for their products. Additionally, contract packaging firms can offer cost-effective solutions by leveraging economies of scale and optimizing packaging processes.

Pharmaceutical companies are increasingly outsourcing their non-core activities, including packaging, to contract packaging firms. This allows them to focus on core competencies like research and development, while benefiting from the expertise and efficiency of contract packaging specialists. Additionally, the pharmaceutical industry is subject to strict regulations and quality standards imposed by health authorities worldwide. Contract packaging companies are well-versed in these regulations, ensuring that pharmaceutical products are packaged and labeled in compliance with Good Manufacturing Practices (GMP) and other relevant guidelines. Other than this, the pharmaceutical market is continuously expanding with new drug developments, personalized medicines, and innovative medical devices. Contract packaging firms offer customized and flexible solutions to accommodate the diverse packaging requirements of these products. Besides this, contract packaging offers cost advantages to pharmaceutical companies by eliminating the need for heavy investments in packaging infrastructure and equipment. Instead, they can leverage the capabilities of established contract packaging providers, resulting in cost savings. In line with this, the global pharmaceutical industry is witnessing significant growth, especially in emerging markets. As pharmaceutical companies expand their reach to new regions, they seek reliable contract packaging partners to ensure efficient and compliant packaging in diverse markets. Furthermore, contract packaging companies are continually adopting advanced technologies and automation in their processes. These innovations improve packaging efficiency, reduce errors, and enhance overall productivity, making them attractive partners for pharmaceutical firms. Moreover, increasing awareness about sustainability and environmental impact has led to a growing demand for eco-friendly and recyclable packaging solutions. Contract packaging companies are aligning their offerings with these green initiatives to meet market demands.

Pharmaceutical Contract Packaging Market Trends/Drivers:

Increasing Outsourcing Trend

Pharmaceutical companies are increasingly turning to contract packaging firms to handle their packaging needs. This shift is primarily driven by the desire to focus on core competencies, such as drug development and marketing, while entrusting the specialized task of packaging to experienced professionals. By outsourcing packaging, pharmaceutical companies can streamline their operations, reduce operational costs, and improve overall efficiency. Contract packaging firms offer expertise in packaging materials, design, and regulatory compliance, which allows pharmaceutical companies to deliver high-quality products to the market in a timely manner. Additionally, outsourcing provides the flexibility to adapt to fluctuations in product demand, allowing pharmaceutical companies to respond swiftly to changing market dynamics.

Stringent Regulatory Compliance

The pharmaceutical industry is heavily regulated by various health authorities worldwide to ensure patient safety and product efficacy. Compliance with Good Manufacturing Practices (GMP) and other regulatory guidelines is paramount for pharmaceutical companies. Contract packaging firms specialize in adhering to these strict regulations, as they possess in-depth knowledge of the applicable quality standards and industry best practices. Their expertise ensures that pharmaceutical products are accurately labeled, packaged, and traceable throughout the supply chain, reducing the risk of non-compliance and potential legal issues. By partnering with contract packaging providers, pharmaceutical companies can maintain their reputation for producing safe and reliable products, while mitigating the risks associated with regulatory non-compliance.

Rising Demand for Medications and Medical Devices

The global pharmaceutical market is continuously expanding, with increasing demand for medications and medical devices across diverse regions. As pharmaceutical companies seek to penetrate new markets, they encounter unique packaging requirements and regional regulations. Contract packaging firms offer localized expertise and capabilities, enabling pharmaceutical companies to navigate the complexities of different markets seamlessly. These firms can adapt packaging designs, labeling, and language translations to comply with local regulations and cultural preferences. By partnering with contract packaging providers, pharmaceutical companies can efficiently enter new markets, capitalize on growth opportunities, and reach a broader customer base. This market expansion strategy allows pharmaceutical companies to extend their market presence while minimizing logistical challenges and ensuring a consistent and compliant packaging approach.

Pharmaceutical Contract Packaging Industry Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the global pharmaceutical contract packaging market report, along with forecasts at the global and regional levels for 2024-2032. Our report has categorized the market based on industry, type and packaging.

Breakup by Industry:

Small Molecule

Biopharmaceutical

Vaccine

The report has provided a detailed breakup and analysis of the market based on the industry. This includes small molecule, biopharmaceutical, and vaccine.

The small molecule pharmaceutical industry encompasses a broad range of traditional drugs that consist of low molecular weight compounds. These drugs are typically synthesized through chemical processes, and they constitute a significant portion of the pharmaceutical market. Small molecule drugs are widely used to treat various medical conditions and diseases, including cardiovascular disorders, infectious diseases, and metabolic disorders. Due to their relatively simple structure, small molecules can be easily mass-produced and formulated into different dosage forms, such as tablets and capsules. They also have a well-established manufacturing and packaging process, making them cost-effective to produce and distribute. The small molecule pharmaceutical industry remains a vital segment of the overall pharmaceutical market and continues to experience steady growth due to the constant demand for therapeutics targeting prevalent medical conditions.

The biopharmaceutical industry focuses on the development and production of pharmaceutical products derived from biological sources, such as living organisms or their components. Biopharmaceuticals include a wide range of products like monoclonal antibodies, vaccines, recombinant proteins, and gene therapies. These products are often more complex in structure and require advanced manufacturing processes, including biotechnology techniques like cell culture and genetic engineering. The biopharmaceutical sector has witnessed significant growth in recent years due to the increasing prevalence of chronic diseases, personalized medicine approaches, and advancements in biotechnology research. Biopharmaceutical products offer targeted and precise treatments, which have revolutionized disease management and patient care. As a result, this industry has become a key driver of innovation and growth within the pharmaceutical market.

The vaccine industry is dedicated to the development, manufacturing, and distribution of vaccines that prevent infectious diseases and protect public health. Vaccines are biological products designed to stimulate an immune response, providing immunity against specific pathogens. They play a crucial role in preventing the spread of communicable diseases and reducing the burden of infectious outbreaks. The vaccine industry has experienced remarkable growth and technological advancements, particularly in response to global health challenges like the COVID-19 pandemic. Vaccine development requires rigorous testing, clinical trials, and adherence to stringent regulatory standards to ensure safety and efficacy. The ongoing research in immunology and molecular biology continues to drive the innovation of novel vaccines to combat emerging diseases and improve public health outcomes globally. As governments and healthcare organizations prioritize vaccination programs, the vaccine industry remains a vital and indispensable component of the pharmaceutical market.

Breakup by Type:

Sterile

Non-Sterile

Sterile pharmaceutical contract packaging holds the largest share in the market

A detailed breakup and analysis of the market based on the type has also been provided in the report. This includes sterile and non-sterile. According to the report, sterile packaging accounted for the largest market share.

Sterile products are those that are free from any viable microorganisms, making them suitable for direct administration into the body, such as through injections or infusions. They are essential in various medical settings, including hospitals, clinics, and home healthcare. The sterile products are widely used in treating serious and life-threatening medical conditions that require immediate and precise intervention. These products are crucial in emergency situations and surgical procedures, where contamination can have severe consequences. Additionally, the stringent regulatory requirements surrounding the manufacturing and distribution of sterile products contribute to their significance. Health authorities have strict guidelines to ensure the quality and sterility of these products, making the manufacturing process complex and specialized. Moreover, the growing demand for biopharmaceuticals and injectable drugs has further driven the dominance of the sterile segment. As biologics and personalized medicine gain popularity, the need for sterile packaging and administration becomes more pronounced, propelling the growth of this segment within the pharmaceutical market.

Breakup by Packaging:

Plastic Bottles

Caps and Closures

Blister Packs

Prefilled Syringes

Parenteral Vials and Ampoules

Others

Plastic bottles dominate the market

The report has provided a detailed breakup and analysis of the market based on the packaging. This includes plastic bottles caps and closures, blister packs, prefilled syringes, parenteral vials and ampoules, and others. According to the report, plastic bottles represented the largest segment.

Plastic bottles offer a combination of versatility and cost-effectiveness that makes them widely preferred across various industries, including pharmaceuticals. Their lightweight nature and durability make them easy to handle during manufacturing, transportation, and storage, reducing overall logistics costs. Additionally, plastic bottles provide excellent barrier properties, protecting pharmaceutical products from external contaminants, moisture, and UV light. This safeguard helps maintain product integrity and extends shelf life, ensuring that medications and healthcare products remain effective and safe for consumption. Furthermore, plastic bottles come in a wide range of shapes and sizes, allowing for customization to meet specific packaging requirements. This flexibility makes them suitable for packaging various forms of pharmaceuticals, from liquid syrups and oral medications to solid tablets and capsules. Moreover, the recyclability of plastic bottles aligns with growing environmental concerns, as manufacturers and consumers increasingly prioritize sustainable packaging solutions. As the demand for eco-friendly packaging continues to rise, plastic bottles' recyclability contributes to their continued dominance as the largest segment in the pharmaceutical packaging market.

Breakup by Region:

United States

Europe

China

India

Others

The United States exhibits a clear dominance in the market

The report has also provided a comprehensive analysis of all the major regional markets, which include the United States, Europe, China, India, and others. According to the report, the United States was the largest market for pharmaceutical contract packaging.

The U.S. pharmaceutical market is one of the largest and most developed in the world, with a high demand for innovative drugs, medical devices, and healthcare products. The extensive pharmaceutical industry in the U.S. necessitates a robust contract packaging sector to handle the diverse packaging needs of various companies. Additionally, the U.S. pharmaceutical landscape is characterized by a dynamic regulatory environment, with stringent quality and safety standards enforced by agencies such as the Food and Drug Administration (FDA). Contract packaging companies in the U.S. are well-versed in these regulations and adhere to strict compliance protocols, providing assurance to pharmaceutical companies that their products will meet the necessary requirements. Other than this, the U.S. is home to numerous pharmaceutical companies, ranging from multinational corporations to innovative start-ups. Many of these companies prefer to outsource their packaging needs to specialized contract packaging firms to focus on their core competencies and achieve greater operational efficiency. Moreover, the presence of advanced technologies and infrastructure in the U.S. contributes to the country's dominance in the pharmaceutical contract packaging market. These resources enable contract packaging companies to offer a wide array of packaging solutions, including serialization, track-and-trace systems, and customized packaging designs. Furthermore, the U.S. contract packaging industry benefits from a highly skilled and trained workforce with expertise in various aspects of pharmaceutical packaging. This proficiency ensures that contract packaging companies can deliver high-quality and reliable packaging services to their clients.

Competitive Landscape:

Leading contract packaging companies are investing heavily in advanced technologies and automation systems. These investments aim to streamline packaging processes, reduce manual errors, and improve overall operational efficiency. Automation enables faster and more precise packaging, leading to increased production capacities and shorter time-to-market for pharmaceutical products. Additionally, key players in the market are expanding their geographic presence to tap into emerging markets and cater to the growing demand for contract packaging services globally. By establishing facilities in strategic locations, they can provide localized services and offer more cost-effective solutions to pharmaceutical companies seeking to enter new regions. Other than this, environmental sustainability has become a significant concern for consumers and businesses alike. Many key players in the pharmaceutical contract packaging market are incorporating sustainable practices, such as using eco-friendly materials and optimizing packaging designs to reduce waste. These efforts align with the increasing demand for environmentally responsible packaging solutions. Furthermore, to broaden their service offerings and cater to diverse customer needs, key players often engage in collaborations and partnerships. These collaborations may involve joint ventures, technology-sharing agreements, or strategic alliances with pharmaceutical companies and other stakeholders. Such partnerships foster innovation, knowledge exchange, and access to a wider customer base.

The market research report has provided a comprehensive analysis of the competitive landscape in the market. Detailed profiles of all major companies have also been provided.

Key Questions Answered in This Report

• 1. What was the size of the global pharmaceutical contract packaging market in 2023?
• 2. What is the expected growth rate of the global pharmaceutical contract packaging market during 2024-2032?
• 3. What are the key factors driving the global pharmaceutical contract packaging market?
• 4. What has been the impact of COVID-19 on the pharmaceutical contract packaging market?
• 5. What is the breakup of the global pharmaceutical contract packaging market based on the type?
• 6. What is the breakup of the global pharmaceutical contract packaging market based on the packaging?
• 7. What are the key regions in the global pharmaceutical contract packaging market?

Table of Contents

1 Preface

2 Scope and Methodology

• 2.1 Objectives of the Study
• 2.2 Stakeholders
• 2.3 Data Sources
  • 2.3.1 Primary Sources
  • 2.3.2 Secondary Sources
• 2.4 Market Estimation
  • 2.4.1 Bottom-Up Approach
  • 2.4.2 Top-Down Approach
• 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

• 4.1 Overview
• 4.2 Key Industry Trends

5 Global Pharmaceutical Contract Packaging Industry

• 5.1 Market Overview
• 5.2 Market Performance
• 5.3 Impact of COVID-19
• 5.4 Price Analysis
  • 5.4.1 Key Price Indicators
  • 5.4.2 Price Structure
  • 5.4.3 Price Trends
• 5.5 Market Breakup by Industry
• 5.6 Market Breakup by Type
• 5.7 Market Breakup by Packaging
• 5.8 Market Breakup by Region
• 5.9 Market Forecast
• 5.10 SWOT Analysis
  • 5.10.1 Overview
  • 5.10.2 Strengths
  • 5.10.3 Weaknesses
  • 5.10.4 Opportunities
  • 5.10.5 Threats
• 5.11 Value Chain Analysis
  • 5.11.1 Raw Material Procurement
  • 5.11.2 Manufacturing
  • 5.11.3 Marketing
  • 5.11.4 Distribution
  • 5.11.5 Exports
  • 5.11.6 End-Use
• 5.12 Porter's Five Forces Analysis
  • 5.12.1 Overview
  • 5.12.2 Bargaining Power of Buyers
  • 5.12.3 Bargaining Power of Suppliers
  • 5.12.4 Degree of Competition
  • 5.12.5 Threat of New Entrants
  • 5.12.6 Threat of Substitutes
• 5.13 Regulations in Generic Industry
• 5.14 Key Market Drivers and Success Factors

6 Market Breakup by Industry

• 6.1 Small Molecule
  • 6.1.1 Market Trends
  • 6.1.2 Market Forecast
• 6.2 Biopharmaceutical
  • 6.2.1 Market Trends
  • 6.2.2 Market Forecast
• 6.3 Vaccine
  • 6.3.1 Market Trends
  • 6.3.2 Market Forecast

7 Market Breakup by Type

• 7.1 Sterile
  • 7.1.1 Market Trends
  • 7.1.2 Market Forecast
• 7.2 Non-Sterile
  • 7.2.1 Market Trends
  • 7.2.2 Market Forecast

8 Market Breakup by Packaging

• 8.1 Plastic Bottles
  • 8.1.1 Market Trends
  • 8.1.2 Market Forecast
• 8.2 Caps and Closures
  • 8.2.1 Market Trends
  • 8.2.2 Market Forecast
• 8.3 Blister Packs
  • 8.3.1 Market Trends
  • 8.3.2 Market Forecast
• 8.4 Prefilled Syringes
  • 8.4.1 Market Trends
  • 8.4.2 Market Forecast
• 8.5 Parenteral Vials and Ampoules
  • 8.5.1 Market Trends
  • 8.5.2 Market Forecast
• 8.6 Others
  • 8.6.1 Market Trends
  • 8.6.2 Market Forecast

9 Market Breakup by Region

• 9.1 United States
  • 9.1.1 Market Trends
  • 9.1.2 Market Forecast
• 9.2 Europe
  • 9.2.1 Market Trends
  • 9.2.2 Market Forecast
• 9.3 China
  • 9.3.1 Market Trends
  • 9.3.2 Market Forecast
• 9.4 India
  • 9.4.1 Market Trends
  • 9.4.2 Market Forecast
• 9.5 Others
  • 9.5.1 Market Trends
  • 9.5.2 Market Forecast

10 Competitive Landscape

• 10.1 Market Structure
• 10.2 Key Players

11 Pharmaceutical Contract Packaging Process

• 11.1 Product Overview
• 11.2 Detailed Process Flow
• 11.3 Various Types of Unit Operations Involved
• 11.4 Mass Balance and Raw Material Requirements

12 Project Details, Requirements and Costs Involved

• 12.1 Land Requirements and Expenditures
• 12.2 Construction Requirements and Expenditures
• 12.3 Plant Layout
• 12.4 Plant Machinery
• 12.5 Raw Material Requirements and Expenditures
• 12.6 Transportation Requirements and Expenditures
• 12.7 Utility Requirements and Expenditures
• 12.8 Manpower Requirements and Expenditures
• 12.9 Other Capital Investments

13 Loans and Financial Assistance

14 Project Economics

• 14.1 Capital Cost of the Project
• 14.2 Techno-Economic Parameters
• 14.3 Product Pricing and Margins Across Various Levels of the Supply Chain
• 14.4 Taxation and Depreciation
• 14.5 Income Projections
• 14.6 Expenditure Projections
• 14.7 Financial Analysis
• 14.8 Profit Analysis

15 Key Player Profiles